Home Equities Score Cyclerion Therapeutics Inc. (CYCN) stock rises during pre-market trading. Here’s to know...

Cyclerion Therapeutics Inc. (CYCN) stock rises during pre-market trading. Here’s to know why?

Cyclerion Therapeutics Inc. (NASDAQ: CYCN) stock declined by 1.25% at the last close while the CYCN stock price gains by 15.56% in the pre-market trading session. Cyclerion Therapeutics is a clinical-stage biopharmaceutical firm dedicated to developing therapies that help people regain cognitive function. Cyclerion is developing CNS-penetrant, first-in-class sGC stimulators that control a crucial node in a basic CNS signaling circuit.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Significant Development

For the development and marketing of praliciguat, an oral sGC stimulator, CYCN has signed an exclusive worldwide licensing deal with Akebia Therapeutics, a major biopharmaceutical firm focused on kidney disease.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Akebia has secured an exclusive license to study, develop, and market praliciguat internationally under the terms of the contract, and will be entirely responsible for these efforts going forward. Cyclerion is eligible for pre-commercial milestone payments of up to $225 million, including up to $15 million in the first 18 months. Up to $585 million in future research, regulatory, and commercialization milestone payments might be made. Cyclerion is also eligible for sales-based royalties ranging from the single digits-to the high-teens.

Peter Hecht, Chief Executive Officer of Cyclerion commented:

CYCN is delighted to license praliciguat to Akebia, whose established expertise in kidney disease, as well as strong R&D and commercialization capabilities, make it a perfect partner for praliciguat’s future development. This deal gives Cyclerion a significant stake in any potential near- and long-term wealth creation, allowing them to focus on their objective of developing therapies for cognitive impairment, including their key assets CY6463 and CY3018, both of which have shown tremendous clinical promise.

What else?

CYCN revealed a direct private sale of nearly $18 million of Cyclerion common stock to EcoR1 Capital, Slate Path Capital, MFN Partners, Invus, Peter Hecht, Lincoln Park Capital Fund, and Polaris Partners.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Peter Hecht, CEO of Cyclerion stated:

CYCN is grateful for the continued support of this prestigious group of investors. This funding, together with the praliciguat out-license announced today, reaffirms their strategic emphasis on CNS and will help them go on with clinical trials for CY6463 and the development of their next-generation drug, CY3018. CY6463 is now being tested in clinical trials for a variety of neurological illnesses linked with cognitive impairment, an unmet medical need for which CYCN thinks CY6463 has the potential to provide significant therapeutic benefit.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

The Dixie Group Inc. (DXYN) stock surged during pre-market trading given no recent news

The Dixie Group Inc. (NASDAQ: DXYN) stock gained by 11.55% in the pre-market trading session. However, there is no update available regarding this hike...

Why BancorpSouth Bank (BXS) stock plummeted on Friday?

BancorpSouth Bank (BXS) shares plummeted 9.39% in after-hours on Friday, June 18, 2021, and close the weekly business at $25.00 per share. Earlier, BXS's...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?

Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14...

ISun Inc. (ISUN) stock surged during current market trading. Here’s the update

ISun Inc. (NASDAQ: ISUN) stock gained by 19.51% in the current market trading. iSun, based in Burlington, Vermont, is a company built on ideals...

Why Eyenovia Inc. (EYEN) stock price went up in the after-market on Friday?

Eyenovia Inc. (EYEN) shares pop up 8.41% in after-hours on Friday, June 18, 2021, and close the week at $5.80 per share. Earlier, EYEN's...

IM Cannabis Corp. (IMCC) stock surged during after-hour session. Why is it so?

IM Cannabis Corp. (NASDAQ: IMCC) stock gained by 3.01% at last close while the IMCC stock price rises by 7.19% in the after-hours session....

Why BancorpSouth Bank (BXS) stock plummeted on Friday?

BancorpSouth Bank (BXS) shares plummeted 9.39% in after-hours on Friday, June 18, 2021, and close the weekly business at $25.00 per share. Earlier, BXS's...

Related News

IM Cannabis Corp. (IMCC) stock surged during after-hour session. Why is it so?

IM Cannabis Corp. (NASDAQ: IMCC) stock gained by 3.01% at last close while the IMCC stock price rises by 7.19% in the after-hours session....

Victory Capital Holdings Inc. (VCTR) stock declined in the after-hour session. Here’s what you should know?

Victory Capital Holdings Inc. (NASDAQ: VCTR) stock declined by 1.89% at the last close while the VCTR stock price plunged by 0.76% in the...

Anpac Bio-Medical Science Inc. (ANPC) stock soars during pre-market trading. Here’s the update

Anpac Bio-Medical Science Inc. (NASDAQ: ANPC) stock gained by 0.46% at last close while the ANPC stock price surged by 22.40% in the pre-market...

Arrival Inc. (ARVL) stock falls during pre-market trading. Here’s what you should know?

Arrival Inc. (NASDAQ: ARVL) stock plunged by 4.96% at last close while the ARVL stock price declines by 9.68% in the pre-market trading session....

Why Zomedica Corp. (ZOM) stock jumped on Thursday?

Zomedica Corp. (ZOM) shares were climbed 4.04% in after-hours on Thursday, June 17, 2021, and close the day at $0.94 per share. Earlier, ZOM's...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam